Taken together, these results prove that HBx downregulates PTPN13 expression via epigenetic silencing and that DNMT3A physically binds to the PTPN13 promoter at a site −343 to −313 bp upstream of the transcription start site, leading to DNA methylation in hepatoma cells. The gene discussed is PTPN13; the disease is hepatocellular carcinoma.